Počet záznamov: 1
apolipoproteín E4
SYS d053327 LBL 00000nz--a2200000o--4500 005 20250606214925.6 008 060705|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D10.532.091.500.750 065 $a D12.776.070.400.500.750 065 $a D12.776.521.120.500.750 066 $a 01 $c 03 150 $a apolipoproteín E4 $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 665 $a 2007 (1982) $2 eng 665 $a Apolipoproteins E (1982-2006) $2 eng 680 9-
$i A major and the second most common isoform of apolipoprotein E. In humans, Apo E4 differs from APOLIPOPROTEIN E3 at only one residue 112 (cysteine is replaced by arginine), and exhibits a lower resistance to denaturation and greater propensity to form folded intermediates. Apo E4 is a risk factor for ALZHEIMER DISEASE and CARDIOVASCULAR DISEASES. $2 eng 750 -2
$a Apolipoprotein E4 $2 eng 980 $x M
Počet záznamov: 1